Brief: Glenmark Pharma USA To Launch Leucovorin Calcium For Injection USP, 350 Mg/Vial Single-Dose Vial
11/12/2025 05:28
Dec 11 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS: GLENMARK PHARMA - GLENMARK PHARMA USA TO LAUNCH LEUCOVORIN CALCIUM FOR INJECTION USP, 350 MG/VIAL SINGLE-DOSE VIAL Source text: ID:nnAZN4RD10L Further company coverage: GLEN.NS (Reporting by Abhirami G from Bengaluru) ((abhirami.g@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter